Studies of polycyclic aromatic hydrocarbons (PAHs) and its metabolites in PM10, soils, rat 45 livers and cattle urine in Kumasi, Ghana, revealed high concentrations and cancer potency. 46 In addition, WHO and IARC have reported an increase in cancer incidence and respiratory 47 diseases in Ghana. Human urine were therefore collected from urban and control sites to: 48 assess the health effects associated with PAHs exposure using malondialdehyde (MDA) 49 and 8-hydroxy-2-deoxyguanosine (8-OHdG); identify any association between OH-PAHs, 50 MDA, 8-OHdG with age and sex; and determine the relationship between PAHs exposure 51 and occurrence of respiratory diseases. From the results, urinary concentrations of the sum 52 of OH-PAHs (∑OHPAHs) were significantly higher from urban sites compared to the 53 control site. Geometric mean concentrations adjusted by specific gravity, GM SG , indicated 54 2-OHNaphthalene (2-OHNap) (6.01 ± 4.21 ng/mL) as the most abundant OH-PAH, and 55 exposure could be through the use of naphthalene-containing-mothballs in drinking water 56 purification, insect repellent, freshener in clothes and/or "treatment of various ailments". 57
Introduction 74
Polycyclic aromatic hydrocarbons (PAHs) are the 9 th most hazardous substance 75 (ATSDR 2015) and formed during combustion of organic materials such as fuel, wood or 76 grass. They are also found in cigarette smoke and grilled foods. Human and animal 77 exposure to PAHs occur mainly through inhalation of contaminated air or ingestion of soil, 78 food and/or drinking contaminated water (Barranco et al. 2004 ). In humans and animals, 79
PAHs are metabolized by cytochrome P450 enzymes to generate active semiquinones 80 (Penning et al. 2007 ) which are free radical intermediates and can go through redox cycling 81 and generate reactive oxygen species (ROS). The ROS can then cause oxidative 82 modification of DNA and lipids in the body (Palackal et al. 2002) . The DNA adduct, 8-83 hydroxy-2′-deoxyguanosine (8-OHdG), is a useful biomarker of DNA damage to assess 84 human exposure to carcinogenic compounds and malondialdehyde (MDA) is an indicator 85 for oxidative stress and lipid peroxidation (Basu and Marnett 1983) . 86
Epidemiological studies have reported associations between PAHs exposure and urinary 87 MDA and 8-OHdG in children, workers, as well as general population in several countries 88 (Fan et al. 2012a ; Kuang et al. 2013 ; Lee et al. 2012 ). 8-OHdG is very stable, excreted in 89 urine without being metabolized (Valavanidis et al. 2009 ) and measurement could offer a 90 specific and quantitative biomarker indicating oxidative DNA damage caused by ROS 91 which is a risk factor for cancer and cardiovascular disease (Shen and Ong 2000) . Exposure 92 to PAHs have also been associated with adverse respiratory health outcomes, increased 93 cough and wheeze, decreased lung function, bronchitis, nasal symptoms, breathing 94 problems as well as development of asthma in both children and adults (USEPA 1994 PM10 and soils at KNUST were used as reference/control for PAHs studies (Bortey-Sam et 149 al. 2013; . However, because humans could be exposed to PAHs through feed 150 and/or inhalation, the sample collected was measured several times to confirm levels of 151 OHFluorene, 3-OHPhenanthrene-d9, and 13C6-1-OHPyrene). The pH of sample was 176 adjusted to 5.5 using 1 M acetic acid (Wako Pure Chemicals, Osaka, Japan) and incubated 177 overnight at 37 • C. The sample was diluted with 4 mL of Milli-Q water and extracted twice 178 (liquid-liquid extraction) with 10 mL each of n-pentane (Kanto Chemical Corp., Tokyo, 179 Japan) by shaking for 1 h. To reduce the interference of sulfur metabolites, the combined 180 extracts were washed with 2 mL of 1 N AgNO 3 solution (Wako Pure Chemicals, Osaka, 181 Japan), concentrated to 50-100 µL, re-dissolved to 0.5 mL using methanol and filtered 182 (0.20 µm DISMIC-13JP membrane filter, ADVANTEC, Toyo Roshi Kaisha Ltd., Japan) 183 prior to instrumental analysis. All sample preparation steps were performed in darkness (by 184 covering tubes completely with aluminium foil) to avoid possible photodegradation of 185 target analytes. A total of 13 OH-PAHs; 2-hydroxynaphthalene (2-OHNap), 2-186 hydroxyfluorene (2-OHFlu), 3-hydroxyfluorene (3-OHFlu), 9-hydroxyfluorene (9-OHFlu), 187 with the separation of 1-OHPhe and 9-OHPhe, for this reason, the sum of these isomers 195 was used as an abbreviation, 1-9-OHPhe. Similarly, 2-3-OHFlu was used as sum of OHFlu and 3-OHFlu. All results were adjusted by specific gravity and expressed in ng/mL. 
Malondialdehyde, MDA (Elisa kit) 207
Concentrations of urinary MDA were measured according to the manufacturer's 208 instructions using a UV-VIS Spectrophotomer (UV-2600 Shimadzu Corporation, Kyoto, 209 Japan). Briefly, 250 uL of calibrator (0, 1, 2, 3 and 4 µM) or urine sample was added to 10 210 uL of butylated hydroxytoluene (BHT) reagent in a vial. 250 uL each of acid reagent (1 M 211 phosphoric acid) and 2-thiobarbituric acid (TBA) reagent were added and the mixture was 212 vortexed vigorously then incubated at 60 0 C for 1 hr. After centrifugation at 10000 x g for 213 2-3 min, the reaction mixture was transferred into a cuvette and spectra was recorded from 214 400-700 nm. 3 rd derivative analysis was performed at 514 nm. 215 1 mL aliquot of each urine sample was diluted with 2 mL of water (HPLC grade) after 217 spiking with 25 ng/mL of the stable isotope labelled internal standard, (15N5) 8-OHdG. 218
The diluted sample was subjected to solid-phase extraction using Oasis HLB cartridge (3cc, 219 60 mg; Waters Corporation, Milford, MA, USA) that had been primed with 1 mL each of 220 methanol and water. After sample loading, the cartridge was sequentially washed with 3 221 mL of water. 8-OHdG was eluted with 3 mL of water: acetonitrile 
Specific gravity (SG) of human urine 231
To compensate for variations in urine dilution, urinary OH-PAH, MDA and 8-OHdG 232 concentrations were adjusted by specific gravity (SG). In this study SG was used because 233 the use of creatinine (CR) to normalize urinary analyte concentrations could be problematic 234 as CR excretion is not consistent and numerous studies have found considerable inter-and 235 intra-subject variability in CR values and dependence on sex, age, activity and diet 236 (Kesteloot and Joossens 1996) . Additionally, SG was used in this study because exposure 237 to naphthalene is known to increase creatinine levels (USEPA 1994 Nermell et al (2008) . The correction 242 formula applied to each urine concentration was as follows: 243
Where, SG target is the mean specific gravity of human urine per community; SG sample is the 244 specific gravity of a particular sample. 245
Quality control and quality assurance 246

OH-PAHs 247
A mixture of three 13C-isotopically labelled OH-PAHs (13C6-2-OHFlu, 3-OHPhe-d9, 248 and 13C6-1-OHPyr) was spiked into urine samples as internal standard prior to sample 249 preparation and extraction. 13C6-2-OHFlu was used for quantification of metabolite of 250 naphthalene and three metabolites of fluorene. 3-OHPhe-d9 was used for quantification of 251 the five metabolites of phenanthrene and 13C6-1-OHPyr was used for quantification of 1-252
OHPyr, 6-OHChry, 3-OHBeP and 9-OHBaP. 253
Quantitation was performed using internal standard method (five-point calibration; 1, 5, 254 10, 50 and 100 ng/mL), and average correlation coefficients for the calibration curves in 255 human urine were greater or equal to 0.99. The standard solutions (spiked with internal 256 standards) for the calibration curves were prepared in urine in order to normalize 257 differences in interferences between standards and samples. Concentrations of OH-PAHs in 258 urine sample used for this purpose were below the limits of detection (LOD) and 259 differences between this and sample concentration was used in this study. Analytical 260 methods were checked for precision and accuracy. Limits of quantification (LOQs) were 261 calculated based on 10SD/S (SD is the standard deviation of the response of seven 262 replicates of the lowest concentrations of each standard solution measurements and S is the 263 slope of the calibration curve). LOQs (ng/mL) of OH-PAHs were, 0.21 (2-OHNap), 0.18 264 OHPyr) ranged from 92 ± 6.5-96 ± 10.3%. 268
For every batch of 10 samples, a solvent blank, a spiked solvent blank (internal 269 standards spiked into solvent), a matrix spike (internal standards spiked into blank urine), 270 and duplicate sample were analyzed. The average recoveries in spiked solvents blanks 271 ranged from 93 ± 5.2-98 ± 7.6%, and that for matrix spikes was 90 ± 8.9-97 ± 6.4%. 272
Blanks were run periodically and contained no detectable amount of target analyte. The 273 coefficients of variation (CV) of OH-PAH in duplicate samples were less than 15%. 274
MDA and 8-OHdG 275
Similarly, for 8-OHdG, (15N5) 8-OHdG was used as internal standard and spiked into 276 urine samples prior to sample preparation and extraction. Quantification was performed 277 using internal standard method (five-point calibration; 1, 5, 10, 50 and 100 ng/mL). The 278 average correlation coefficients for the calibration curves were greater than 0.99 for both 279 8-OHdG) was 86 ± 9.8%. For every batch of 10 samples, spiked solvent blanks (8-OHdG 281 only) and duplicate samples were analysed and average internal standard recovery for 282 spiked solvents blanks was 104 ± 8.7%. The CV's for duplicate samples were less than or 283 equal to 10% (MDA and 8-OHdG). LOQ for MDA was 0.63 uM. 284 285
Data analysis 286
Data analysis was performed using IBM SPSS v 20 (SPSS Inc., Illinois, USA). 287
Kolmogorov-Smirnov (K-S) and Shapiro-Wilks tests were used to determine the normality 288 of data and were considered statistically significant if p value was less than 0.05. Data was 289 normalized by a base 10 logarithm transformation. Concentrations of OH-PAH below their 290 respective LOQs were replaced with a value of LOQ/2. Geometric mean concentrations (± 291 geometric standard deviation) were used to represent the central tendency of OH-PAH in 292 this study (Wayne 1990 ). Kruskal-Wallis and Wilcoxon tests were used to compare 293 concentrations of OH-PAH in human urine from the study areas and differences were 294 considered statistically significant with p value ˂ 0.05. Pearson's correlation of logged data 295 was used to determine the association between OH-PAHs, MDA, 8-OHdG and age. Mann-296
Whitney U test was also used to compare distribution of OH-PAHs, MDA and 8-OHdG 297 between male and female participants, and considered statistically significant if p value was 298 less than 0.05. To examine the association between naphthalene exposure and occurrence of 299 respiratory symptoms, persistent cough and headache, odds ratios (ORs) were obtained 300 from the logistic regression models at 95% confidence interval (CI). Prior to OR calculation, 301 receiver operating characteristic (ROC) was used to set the threshold values for 2-OHNap 302 which could give most accurate discrimination between the positive and negative 303 symptoms based on the questionnaire administered and the responses in a measurement of 304 concentration of 2-OHNap. Logistic regression analysis was performed to acknowledge the 305 association between high exposure to 2-OHNap (over the threshold) and the number of 306 clinical or respiratory symptoms. Statistical significance level of the tests was set at p ˂ 307 0.05 and statistical analyses were performed JMP 10 statistical software (SAS Institute). 308
Results and discussion 309
Urinary levels of OH-PAHs 310
As shown in Table 1 frequency. The results of specific gravity adjusted geometric mean concentrations (GM SG ± 321 GSD) showed that 2-OHNap (6.01 ± 4.21 ng/mL) was the most abundant urinary OH-PAH 322 in humans from all study sites followed by 2-3-OHFlu (0.526 ± 4.16 ng/mL) > 2-OHPhe 323 (0.171 ± 3.99 ng/mL) ≥ 1-9-OHPhe (0.160 ± 3.70 ng/mL) > 4-OHPhe (0.140 ± 4.79 324 ng/mL) and ≥ 1-OHPyr (0.139 ± 4.44 ng/mL). The GM SG (± GSD) concentration (ng/mL) 325 of the sum of OH-PAHs, ∑OHPAHs (2-OHNap, 2-3-OHFlu, 1-9-OHPhe, 2-OHPhe, 4-326
OHPhe and 1-OHPyr) were significantly higher (p < 0.05) in participants from urban sites 327 compared to those from the control/reference site and decreased in the order, Manhyia 328 (11.6 ± 3.50) > Atonsu (8.09 ± 3.35) ≥ Tafo (8.05 ± 3.24) and > KNUST (1.94 ± 1.60) 329 (Table 1) . Participants who lived within high-traffic areas could be easily affected by 330 traffic-related airborne PAHs (Fan et al. 2012a) . 331
Urinary 2-OHNaphthalene concentrations 332
The GM SG (± GSD) of urinary 2-OHNap in participants from Manhyia (8.53 ± 3.97 333 ng/mL) > Tafo (5.95 ± 4.06 ng/mL) ≥ Atonsu (5.62 ± 4.24 ng/mL) were significantly 334 higher (p < 0.05) compared to levels detected from KNUST participants (1.37 ± 1.88) 335 (Table 1) 
Urinary OHPhenanthrenes and OHFluorenes concentrations 384
The distribution of 2-OHPhe and 4-OHPhe were not significantly different (p > 0.05) 385 among participants in urban sites (Table 1) . However, 1-9-OHPhe was higher (p < 0.05) in 386
Manhyia participants than those in Tafo. Although not significant (p > 0.05), urinary 387 concentrations of 2-OHPhe and 4-OHPhe were higher in participants from urban sites than 388 those from KNUST. However, as shown in Table 1 , 1-9-OHPhe was significantly lower (p 389 < 0.05) from KNUST participants. 1-9 and 4-OH-Phes were most abundant (4.04 and 7.19 390 ng/mL, respectively) in urine of a 22 year old participant who lived in Manhyia and 391 complained of dyspnea. Urinary concentrations of 2-3-OHFlu in participants from urban 392 sites were significantly higher (p < 0.05) than KNUST participants. Also, the urinary levels 393 of 2-3-OHFlu in Manhyia participants was significantly higher (p ˂ 0.05) than levels found 394 in participants from the other urban sites (Table 1) Among the various age groups (Table 3) , there was no significant difference in all 428 measured urinary concentrations of OH-PAHs, MDA and 8-OHdG except for 1-9-OHPhe 429 which was significantly higher (p ˂ 0.05) in age group 61-85 compared to 41-60. Although 430 not significant, ∑OHPAHs were higher in age groups 21-40, 41-60, and 61-85 than 3-20 431 group with MDA and 8-OHdG highest in age groups 21-60 (Table 3 ). The lower 432 concentrations at this age (3-20 years) could reflect lower exposure to PAHs and thus 433 potentially reduce the health effects among the group as suggested by Perera et al. (2014) . 434
This result is consistent with the 2012 Cancer Summary data from the Kumasi Cancer 435 Registry (KsCR) (Population-based cancer registry, PBCR), where the incidence rate of 436 cancer in Kumasi is stable or low from 0-19 years, and gradually increases with age and the 437 peak incidence being at ages 40-64 (males) and 30-69 (females), then decreases around age . In addition to other exposure sources, this could be due to the fact that the daily 452 tobacco smoking, which contains other contaminants other than PAHs, was 4 times higher 453 in males (7) than females (1.7) (WHO 2011) and percent of tobacco use in persons 15 years 454 of age or older in Ghana was 13 times higher in males (9.5) than females (0.7) (WHO 455 2010). Females could also be exposed to higher levels of PAHs because they usually 456 burned firewood/charcoal for cooking and/or cooked (fried, grilled, smoked, etc.) for their 457 families. These activities have been associated with PAHs exposure in previous studies 458 (Motorykin et al. 2015) . 459 2-OHNap was 3 times as high in females than males (Table 4 ). This trend is similar to 460 studies by Orjuela et al. (2012) and Guo et al. (2014) , in which the urinary levels of 1-461
OHNap, 2-OHNap, ∑OHNap, 1-OHPhe, 9-OHPhe, ∑OHPhe, 1-OHPyr, and ∑OHPAHs 462 were all significantly or marginally higher among women than men workers. However, 463 study by Thai et al. (2016) in human urine showed no association between sex and urinary 464 OH-PAHs concentrations. When exposed to similar levels of PAHs, women had 465 significantly higher micronuclei frequencies than men (Guo et al. 2014) . Emerging 466 evidence also indicates that women may be at greater risk of lung cancer than men, because 467 the elevated activity of CYP1A1 enzymes in women can produce higher levels of DNA 468 adducts, and women have lower DNA repair capacity than men (Mollerup et al. 2006; 469 Uppstad et al. 2011) . In contrast, Sul et al. (2012) and Bartolomé et al. (2015) observed 470 significantly higher levels of urinary 2-OHNap and ∑OHPhes, respectively, in men than 471 females, and suggested that gender were predictors of urinary 2-OHNap concentrations (Sul 472 et al. 2012 ). These differences could be due to variations in levels and route of exposure to 473 PAHs. Additionally, several non-pharmacogenetic factors such as age, gender, disease 474 factors or exposure to environmental pollutants might contribute to the expression and 475 regulation of hepatic P450 in human (Guengerich 2002; Nebbia 2001) . 476
Association between naphthalene exposure and respiratory/clinical symptoms 477
For respiratory effects due to PAHs exposure, the study focused on 2-OHNap since it 478 was the most abundant metabolite detected in human urine in Kumasi. Based on ROC, 479 threshold values obtained were used to determine the OR (Table 5 ). OR analysis was used 480 to identify the association between naphthalene exposure and occurrence of respiratory 481 symptoms, persistent cough and headache. As shown in Table 5 , exposure to naphthalene at 482 concentrations above the threshold significantly (p ˂ 0.05) increases the odds of occurrence 483 of tachycardia (OR = 3.36, CI: 1.39-8.1), dyspnea (OR = 3.07, CI: 1.27-7.43), persistent 484 cough (OR = 2.68, CI: 1.43-5.05) and persistent headache (OR = 1.82, CI: 1.02-3.26) 485 (Table 5 ). 2-OHNap concentration over 16.5 ng/mL increased the occurrence of asthma in 486 both sexes though the association was not significant (OR = 5.11; CI: 0.82-31.5). 487
Gender differences revealed that, significant associations (p ˂ 0.05) were found between 488 exposure to naphthalene and persistent headache (OR = 2.51, CI: 1.04-4.29) or dyspnea 489 (OR = 3.30, CI: 1.21-8.99) in female, although not in male (Table 5 ). There is substantial 490 literature showing that female animals are more susceptible to naphthalene toxicity and that 491 repair of airway epithelium occurs more slowly than in males (Oliver et Living in high-traffic areas and/or exposure to diesel exhaust particles have been 499 associated with increased respiratory symptoms and impaired lung function in humans 500 (Gehring et al. 2002; Wyler et al. 2000) . The high occurrences and odds of respiratory 501 symptoms, persistent cough and headache in Kumasi residents could be due to high 502 exposure to PAHs from fuel, wood/grass combustion and also exposure through the use of 503 naphthalene-containing-mothballs in drinking water purification, treatment of various 504 ailment, insect repellent and/or freshener in clothes. 505
Human health risk implications 506
The study revealed that there was no significant association (p > 0.05) between urinary 507 concentrations of OH-PAHs with MDA and 8-OHdG from KNUST participants ( Table 2) . 508
However, at the urban sites, urinary concentrations of 2-OHNap, 2-3-OHFlu, 2-OHPhe, 1-509 9-OHPhe, 4-OHPhe, ΣOHPhe and ΣOHPAHs increased significantly (p < 0.05) as MDA 510 increased (Table 2) . Additionally, at the urban sites, there was no significant association 511 between 8-OHdG and the OH-PAHs studied except 4-OHPhe (p < 0.05). This trend is quite 512 similar to previous studies where urinary 8-OHdG and/or MDA gradually increased as the 513 environmental exposure levels to PAHs increased (Kuang et Similarly, urinary 8-OHdG have also been indicated as a risk factor for atherosclerosis, 522 diabetes, and various cancers (Wu et al. 2004 ). Increased oxidative stress levels reportedly 523 correlated with many chronic degenerative diseases such as allergic inflammatory diseases 524 (Bartsch and Nair 2004) , obesity and atherosclerosis (Kobayashi et al. 2011; Wu et al. 525 2004) which were some of the symptoms obtained from participants in this study during the 526 face-to-face interview. For instance, the questionnaire revealed that 10% of participants 527 were diabetics and 2% had arthritis. Of 33 participants that we calculated body mass index, 528 33% (11) were overweight and 21% (7) were obese. In previous studies, a positive 529 association was observed between urinary biomarkers of 1 and 2-hydroxynapthol, 2-OHPhe 530 and summed low molecular weight (LMW) PAH biomarkers, and diabetes mellitus 531 Ghana and naphthalene exposure through vehicular emissions and the frequent use of 540 naphthalene-containing-mothballs in drinking water purification, insect repellent, freshener 541 in clothes have contributed significantly. Urinary concentrations of the ∑OHPAHs were 542 significantly higher from urban sites compared to the control site. The present study 543 showed a significant sex difference with higher levels of urinary OH-PAHs in women than 544 men. The study revealed that exposure to naphthalene significantly increases the occurrence 545 of persistent cough, persistent headache, tachycardia and dyspnea. Gender differences 546 revealed that the occurrence of persistent headache and dyspnea due to naphthalene 547 exposure were significantly higher in females than males. There was no association 548 between urinary OH-PAHs concentrations and age, with MDA and 8-OHdG highest in age 549 n: number of samples; nd: below limit of quantification; GM: geometric mean concentration adjusted by specific gravity; 849 GSD: geometric standard deviation; # indicates concentrations in micro molar (uM); different letters (a and b) within a column 850 indicates significant differences (p ˂ 0.05) among age groups 851 38 n: number of samples; nd: below limit of quantification; GM: geometric mean concentration adjusted by specific gravity; 855 GSD: geometric standard deviation; different letters (a and b) within a column indicate significant differences (Student's T-856
Test; p ˂ 0.05); # indicates concentrations in micro molar (uM) 857 858 859 860 861 862 
